Diagnosis of invasive fungal disease in children: a narrative review

References

• Steinbach WJ, Roilides E, Berman D, et al. Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates. Pediatr Infect Dis J. 2012;31:1252–1257.
   PubMed Web of Science ®Google Scholar
• Wattier RL, Dvorak CC, Hoffman JA, et al. A prospective, international cohort study of invasive mold infections in children. J Pediatric Infect Dis Soc. 2015;4:313–322.
   PubMed Web of Science ®Google Scholar
• Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology. 6th ed. Philadelphia, PA, USA: Elsevier Mosby; 2009.
   Google Scholar
• Oz Y, Kiraz N. Diagnostic methods for fungal infections in pediatric patients: microbiological, serological and molecular methods. Expert Rev Anti Infect Ther. 2011;9:289–298.
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Verweij PE, Arendrup MC, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect. 2012;18(Suppl 7):9–18.
   PubMed Web of Science ®Google Scholar
• Clancy CJ, Nguyen MH. Finding the missing 50% of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis. 2013;56:1284–1292.
   PubMed Web of Science ®Google Scholar
• Ostrosky-Zeichner L. Invasive mycoses: diagnostic challenges. Am J Med. 2012;125:S14–24.
   PubMed Web of Science ®Google Scholar
• Arendrup MC, Fisher BT, Zaoutis TE. Invasive fungal infections in the paediatric and neonatal population: diagnostics and management issues. Clin Microbiol Infect. 2009;15:613–624.
   PubMed Web of Science ®Google Scholar
• Downey LC, Smith PB, Benjamin DK, et al. Recent advances in the detection of neonatal candidiasis. Curr Fungal Infect Rep. 2010;4:17–22.
   PubMedGoogle Scholar
• Baron EJ, Miller JM, Weinstein MP, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013. Clin Infect Dis. 2013;57:22–121.
   PubMed Web of Science ®Google Scholar
• Seth R, Xess I, Jana M. Diagnosis of invasive fungal infections in children. Indian Pediatr. 2019;56:229–236.
   PubMed Web of Science ®Google Scholar
• Berenguer J, Buck M, Witebsky F, et al. Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis disseminated versus single-organ infection. Diagn Microbiol Infect Dis. 1993;17:103–109.
   PubMed Web of Science ®Google Scholar
• Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J. 2007;30:782–800. Available from http://erj.ersjournals.com/cgi/doi/10.1183/09031936.00062206
   PubMed Web of Science ®Google Scholar
• Vanderbeke L, Spriet I, Breynaert C, et al. Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment. Curr Opin Infect Dis. 2018;31:471–480.
   PubMed Web of Science ®Google Scholar
• Schauwvlieghe AFAD, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018;6:782–792.
   PubMed Web of Science ®Google Scholar
• Lanternier F, Cypowyj S, Picard C, et al. Primary immunodeficiencies underlying fungal infections. Curr Opin Pediatr. 2013;25:736–747.
   PubMed Web of Science ®Google Scholar
• Perfect JR, Cox GM, Lee JY, et al. The impact of culture isolation of aspergillus species: A hospital-based survey of aspergillosis. Clin Infect Dis. 2001;33:1824–1833.
   PubMed Web of Science ®Google Scholar
• Chellapandian DB, Lehrnbecher T, Phillips B, et al. Bronchoalveolar lavage and lung biopsy in patients with cancer and hematopoietic stem-cell transplantation recipients: A systematic review and meta-analysis. J Clin Oncol. 2015;33:501–509.
   PubMed Web of Science ®Google Scholar
• Hodgman EI, Compton J, Qureshi FG, et al. Diagnosis of invasive fungal infection among pediatric oncology patients. J Pediatr Hematol Oncol. 2019;41:596–600.
   PubMed Web of Science ®Google Scholar
• Dekio F, Bhatti TR, Zhang SX, et al. Positive impact of fungal histopathology on immunocompromised pediatric patients with histology-proven invasive fungal infection. Am J Clin Pathol. 2015;144:61–67.
   PubMed Web of Science ®Google Scholar
• de Mol M, de Jongste JC, van Westreenen M, et al. Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan. Pediatr Pulmonol. 2013 [2019 Sep 16];48:789–796.
   PubMed Web of Science ®Google Scholar
• Batra S, Li B, Underhill N, et al. Clinical utility of bronchoalveolar lavage and respiratory tract biopsies in diagnosis and management of suspected invasive respiratory fungal infections in children. Pediatr Blood Cancer. 2015;62:1579–1586.
   PubMed Web of Science ®Google Scholar
• Rossoff J, Locke M, Helenowski IB, et al. Cost analysis of bronchoalveolar lavage and respiratory tract biopsies in the diagnosis and management of suspected invasive fungal infection in children with cancer or who have undergone stem cell transplant. Pediatr Blood Cancer. 2019;66:e27598.
   Web of Science ®Google Scholar
• Mulvey CL, Rizzi MD, Buzi A. Predictive ability of bedside nasal endoscopy to diagnose invasive fungal sinusitis in a pediatric population. Int J Pediatr Otorhinolaryngol. 2018;115:82–88.
   PubMed Web of Science ®Google Scholar
• Pana Z-D, Vikelouda K, Roilides E. Diagnosis of invasive fungal diseases in pediatric patients. Expert Rev Anti Infect Ther.2016; 14:1203–1213.
   PubMed Web of Science ®Google Scholar
• Huppler AR, Fisher BT, Lehrnbecher T, et al. Role of molecular biomarkers in the diagnosis of invasive fungal diseases in children. J Pediatric Infect Dis Soc. 2017;6:S32–S44.
   PubMed Web of Science ®Google Scholar
• Lehrnbecher T, Hassler A, Groll AH, et al. Diagnostic approaches for invasive aspergillosis-Specific considerations in the pediatric population. Front Microbiol Frontiers Media SA. 2018;9: 519.
   PubMed Web of Science ®Google Scholar
• Lehrnbecher T, Robinson PD, Fisher BT, et al. Galactomannan, ß-D-Glucan, and polymerase chain reaction-based assays for the diagnosis of invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: a systematic review and meta-analysis. Clin Infect Dis. 2016;63:1340–1348.
   PubMed Web of Science ®Google Scholar
• Lehrnbecher T. The clinical management of invasive mold infection in children with cancer or undergoing hematopoietic stem cell transplantation. Expert Rev Anti Infect Ther. 2019;17:489–499.
   PubMed Web of Science ®Google Scholar
• Rohrlich P, Sarfati J, Mariani P, et al. Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis J. 1996;15:232–237.
   PubMed Web of Science ®Google Scholar
• Teisseyre J, Kalicinski P, Markiewicz-Kijewska M, et al. Aspergillosis in children after liver transplantation: single center experience. Pediatr Transplant. 2007;11:868–875.
   PubMed Web of Science ®Google Scholar
• Hayden R, Pounds S, Knapp K, et al. Galactomannan antigenemia in pediatric oncology patients with invasive aspergillosis. Pediatr Infect Dis J. 2008;27:815–819.
   PubMed Web of Science ®Google Scholar
• Desai R, Ross LA, Hoffman JA. The role of bronchoalveolar lavage galactomannan in the diagnosis of pediatric invasive aspergillosis. Pediatr Infect Dis J. 2009;28:283–286.
   PubMed Web of Science ®Google Scholar
• Castagnola E, Furfaro E, Caviglia I, et al. Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation. Clin Microbiol Infect. 2010;16:1197–1203.
   PubMed Web of Science ®Google Scholar
• Fisher BT, Zaoutis TE, Park JR, et al. Galactomannan antigen testing for diagnosis of invasive aspergillosis in pediatric hematology patients. J Pediatric Infect Dis Soc. 2012;1:103–111.
   PubMedGoogle Scholar
• Badiee P, Alborzi A, Karimi M, et al. Diagnostic potential of nested PCR, galactomannan EIA, and beta-D-glucan for invasive aspergillosis in pediatric patients. J Infect Dev Ctries. 2012;6:352–357.
   PubMed Web of Science ®Google Scholar
• Choi SH, Kang ES, Eo H, et al. Aspergillus galactomannan antigen assay and invasive aspergillosis in pediatric cancer patients and hematopoietic stem cell transplant recipients. Pediatr Blood Cancer. 2013;60:316–322.
   PubMed Web of Science ®Google Scholar
• Jha AK, Bansal D, Chakrabarti A, et al. Serum galactomannan assay for the diagnosis of invasive aspergillosis in children with haematological malignancies. Mycoses. 2013;56:442–448.
   PubMed Web of Science ®Google Scholar
• Reinwald M, Konietzka CAM, Kolve H, et al. Assessment of Aspergillus-specific PCR as a screening method for invasive aspergillosis in paediatric cancer patients and allogeneic haematopoietic stem cell recipients with suspected infections. Mycoses. 2014;57:537–543.
   PubMed Web of Science ®Google Scholar
• Koltze A, Rath P, Schöning S, et al. ß-D-glucan screening for detection of invasive fungal disease in children undergoing allogeneic hematopoietic stem cell transplantation. J Clin Microbiol. 2015;53:2605–2610.
   PubMed Web of Science ®Google Scholar
• Tabone MD, Vu-Thien H, Latge J-P, et al. Value of galactomannan detection by sandwich enzyme-linked immunosorbant assay in the diagnosis and follow-up of invasive aspergillosis. Opport Pathog. 1997;9:7–13.
   Google Scholar
• Gefen A, Zaidman I, Shachor-Meyouhas Y, et al. Serum galactomannan screening for diagnosis of invasive pulmonary aspergillosis in children after stem cell transplantation or with high-risk leukemia. Pediatr Hematol Oncol. 2015;32:146–152.
   PubMed Web of Science ®Google Scholar
• Dinand V, Anjan M, Oberoi JK, et al. Threshold of galactomannan antigenemia positivity for early diagnosis of invasive aspergillosis in neutropenic children. J Microbiol Immunol Infect. 2016;49:66–73.
   PubMedGoogle Scholar
• Badiee P, Hashemizadeh Z, Ramzi M, et al. Non-invasive methods to diagnose fungal infections in pediatric patients with hematologic disorders. Jundishapur J Microbiol. 2016;9:e41573.
   Web of Science ®Google Scholar
• Gupta P, Ahmad A, Khare V, et al. Comparative evaluation of pan-fungal real-time PCR, galactomannan and (1–3)-ß-D-glucan assay for invasive fungal infection in paediatric cancer patients. Mycoses. 2017;60:234–240.
   PubMed Web of Science ®Google Scholar
• Avcu G, Karapinar DY, Akinci AB, et al. Utility of the serum galactomannan assay for the diagnosis of invasive aspergillosis in children with acute lymphoblastic leukemia. Int J Infect Dis. 2017;54:8–12.
   PubMed Web of Science ®Google Scholar
• Sav H, Atalay MA, Koc AN, et al. Utility of the Aspergillus galactomannan antigen testing for neutropenic paediatric patients. Infez Med. 2017;25:38–44.
   PubMedGoogle Scholar
• Zheng F, Zha H, Yang D, et al. Diagnostic values and limitations of (1,3)-ß-d-glucans and galactomannan assays for invasive fungal infection in patients admitted to pediatric intensive care unit. Mycopathologia. 2017;182:331–338.
   PubMed Web of Science ®Google Scholar
• Loeffler J, Hafner J, Mengoli C, et al. Prospective biomarker screening for diagnosis of invasive aspergillosis in high-risk pediatric patients. J Clin Microbiol. 2017;55:101–109.
   PubMed Web of Science ®Google Scholar
• Qiu KY, Liao XY, Huang K, et al. The early diagnostic value of serum galactomannan antigen test combined with chest computed tomography for invasive pulmonary aspergillosis in pediatric patients after hematopoietic stem cell transplantation. Clin Transplant. 2019; 33:e13641.
   Web of Science ®Google Scholar
• Armenian SH, Nash KA, Kapoor N, et al. Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients. J Pediatr Hematol Oncol. 2009;31:920–926.
   PubMed Web of Science ®Google Scholar
• Sulahian A, Boutboul F, Ribaud P, et al. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer. 2001;91:311–318.
   PubMed Web of Science ®Google Scholar
• Mohammadi S, Khalilzadeh S, Goudarzipour K, et al. Bronchoalveolar galactomannan in invasive pulmonary aspergillosis: A prospective study in pediatric patients. Med Mycol. 2015;53:709–716.
   PubMed Web of Science ®Google Scholar
• Bialek R, Moshous D, Casanova J-L, et al. Aspergillus antigen and PCR assays in bone marrow transplanted children. Eur J Med Res. 2002;7:177–180.
   PubMed Web of Science ®Google Scholar
• Herbrecht R, Letscher-Bru V, Oprea C, et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol. 2002;20:1898–1906.
   PubMed Web of Science ®Google Scholar
• Challier S, Boyer S, Abachin E, et al. Development of a serum-based taqman real-time PCR assay for diagnosis of invasive aspergillosis. J Clin Microbiol. 2004;42:844–846.
   PubMed Web of Science ®Google Scholar
• El-Mahallawy HA, Shaker HH, Ali Helmy H, et al. Evaluation of pan-fungal PCR assay and Aspergillus antigen detection in the diagnosis of invasive fungal infections in high risk paediatric cancer patients. Med Mycol. 2006;44:733–739.
   PubMed Web of Science ®Google Scholar
• Hovi L, Saxen H, Saarinen-Pihkala UM, et al. Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders. Pediatr Blood Cancer. 2007;48:28–34.
   PubMed Web of Science ®Google Scholar
• Steinbach WJ, Addison RM, McLaughlin L, et al. Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients. Pediatr Infect Dis J. 2007;26:558–564.
   PubMed Web of Science ®Google Scholar
• Goudjil S, Kongolo G, Dusol L, et al. (1–3)-ß-D-glucan levels in candidiasis infections in the critically ill neonate. J Matern Neonatal Med. 2013;26:44–48.
   PubMed Web of Science ®Google Scholar
• Zhao D, Qiu G, Luo Z, et al. Platelet parameters and (1, 3)-ß-D-Glucan as a diagnostic and prognostic marker of invasive fungal disease in preterm infants. PLoS One. 2015;10.
   Web of Science ®Google Scholar
• Cornu M, Goudjil S, Kongolo G, et al. Evaluation of the (1,3)-ß-D-glucan assay for the diagnosis of neonatal invasive yeast infections. Med Mycol. 2018;56:78–87.
   PubMed Web of Science ®Google Scholar
• Shabaan AE, Elbaz LM, El-Emshaty WM, et al. Role of serum (1,3)-ß-D-glucan assay in early diagnosis of invasive fungal infections in a neonatal intensive care unit. J Pediatr (Rio J). 2018;94:559–565.
   PubMed Web of Science ®Google Scholar
• Zhao L, Tang J-Y, Wang Y, et al. Value of plasma beta-Glucan in early diagnosis of invasive fungal infection in children. Zhongguo Dang Dai Er Ke Za Zhi. 2009;11:905–908.
   PubMedGoogle Scholar
• Liu Y, Chen F, Zhu X, et al. Evaluation of a novel plasma (1,3)-ß-D-glucan detection assay for diagnosis of candidemia in pediatric patients. J Clin Microbiol. 2015;53:3017–3020.
   PubMed Web of Science ®Google Scholar
• Guitard J, Tabone MD, Senghor Y, et al. Detection of ß-D-glucan for the diagnosis of invasive fungal infection in children with hematological malignancy. J Infect. 2016;73:607–615.
   PubMed Web of Science ®Google Scholar
• Calitri C, Caviglia I, Cangemi G, et al. Performance of 1,3-ß-D-glucan for diagnosing invasive fungal diseases in children. Mycoses. 2017;60:789–795.
   PubMed Web of Science ®Google Scholar
• Salvatore CM, Rath P, Schoering S, et al. Prospective study and analytical per- formance of serum (1->3)-ß-d-glucan in pediatric patients. Infectious Diseases Society of America – ID Week New Orleans-LA 2016
   Google Scholar
• Salvatore CM, Chen TK, Toussi SS, et al. (1→3)-β-d-glucan in cerebrospinal fluid as a biomarker for Candida and Aspergillus infections of the central nervous system in pediatric patients. J Pediatric Infect Dis Soc. 2016;49:277–286.
   Google Scholar
• Dendis M, Horváth R, Michálek J, et al. PCR-RFLP detection and species identification of fungal pathogens in patients with febrile neutropenia. Clin Microbiol Infect. 2003;9:1191–1202.
   PubMed Web of Science ®Google Scholar
• Cesaro S, Stenghele C, Calore E, et al. Assessment of the lightcycler PCR assay for diagnosis of invasive aspergillosis in paediatric patients with onco-haematological diseases. Mycoses. 2008;51:497–504.
   PubMed Web of Science ®Google Scholar
• Hummel M, Spiess B, Roder J, et al. Detection of Aspergillus DNA by a nested PCR assay is able to improve the diagnosis of invasive aspergillosis in paediatric patients. J Med Microbiol. 2009;58:1291–1297.
   PubMed Web of Science ®Google Scholar
• Landlinger C, Preuner S, Bašková L, et al. Diagnosis of invasive fungal infections by a real-time panfungal PCR assay in immunocompromised pediatric patients. Leukemia. 2010;24:2032–2038.
   PubMed Web of Science ®Google Scholar
• Mandhaniya S, Iqbal S, Sharawat SK, et al. Diagnosis of invasive fungal infections using real-time PCR assay in paediatric acute leukaemia induction. Mycoses. 2012;55:372–379.
   PubMed Web of Science ®Google Scholar
• Lin M, Lu H, Chen W. Improving efficacy of antifungal therapy by polymerase chain reaction–based strategy among febrile patients with neutropenia and cancer. Clin Infect Dis. 2001;33:1621–1627.
   PubMed Web of Science ®Google Scholar
• Montagna MT, Lovero G, De Giglio O, et al. Invasive fungal infections in neonatal intensive care units of Southern Italy: a multicentre regional active surveillance (AURORA project). J Prev Med Hyg. 2010;51:125–130.
   PubMedGoogle Scholar
• Montagna MT, Coretti C, Lovero G, et al. Diagnostic performance of 1?3-ß-d-glucan in neonatal and pediatric patients with Candidemia. Int J Mol Sci. 2011;12:5871–5877.
   PubMed Web of Science ®Google Scholar
• Verduyn Lunel FM, Voss A, Kuijper EJ, et al. Detection of the Candida antigen mannan in cerebrospinal fluid specimens from patients suspected of having Candida meningitis. J Clin Microbiol. 2004;42:867–870.
   PubMed Web of Science ®Google Scholar
• Dorko E, Virágová S, Pilipcinec E, et al. Detection of anti-Candida antibodies in neonates from a neonatal intensive care unit. Folia Microbiol (Praha). 2002;47:297–301.
   PubMed Web of Science ®Google Scholar
• Schreiber JR, Maynard E, Lew MA. Candida antigen detection in two premature neonates with disseminated candidiasis. Pediatrics. 1984;74:838–841.
   PubMed Web of Science ®Google Scholar
• Oliveri S, Trovato L, Betta P, et al. Experience with the Platelia Candida ELISA for the diagnosis of invasive candidosis in neonatal patients. Clin Microbiol Infect. 2008;14:391–393.
   PubMed Web of Science ®Google Scholar
• Posteraro B, Sanguinetti M, Boccia S, et al. Early mannan detection in bronchoalveolar lavage fluid with preemptive treatment reduces the incidence of invasive Candida infections in preterm infants. Pediatr Infect Dis J. 2010;29:844–848.
   PubMed Web of Science ®Google Scholar
• Vento G, Lio A, Tirone C, et al. Association of high levels of a-defensins and S100A proteins with Candida mannan detection in bronchoalveolar lavage fluid of preterm neonates. Pediatr Res. 2013;74:19–25.
   PubMed Web of Science ®Google Scholar
• De Pauw B, Walsh TJ, Donnelly JP, et al. Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/ MSG) Consensus Group. Clin Infect Dis. 2008;46:1813–1821.
   PubMed Web of Science ®Google Scholar
• Jaeschke R. Users’ guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The evidence-based medicine working group. JAMA J Am Med Assoc. 1994;271:703–707.
   PubMed Web of Science ®Google Scholar
• McGee S. Simplifying likelihood ratios. J Gen Intern Med. 2002;17:647–650.
   Web of Science ®Google Scholar
• Schünemann HJ, Oxman AD, Brozek J, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008;336:1106–1110.
   PubMed Web of Science ®Google Scholar
• Powers DMW. Evaluation: from precision, recall and F-measure to ROC, informedness, markedness & correlation. J Mach Learn Tech. 2011;2:37–63.
   Google Scholar
• Lehrnbecher T, Robinson P, Fisher B, et al. Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. J Clin Oncol. 2017;35:2082–2094.
   PubMed Web of Science ®Google Scholar
• Mularoni A, Furfaro E, Faraci M, et al. High levels of ß-D-Glucan in immunocompromised children with proven invasive fungal disease. Clin Vaccine Immunol. 2010;17:882–883.
   PubMed Web of Science ®Google Scholar
• Guo J, Wu Y, Lai W, et al. The diagnostic value of (1,3)-ß-D-glucan alone or combined with traditional inflammatory markers in neonatal invasive candidiasis. BMC Infect Dis. 2019;19:716.
   PubMed Web of Science ®Google Scholar
• Del Bono V, Mularoni A, Furfaro E, et al. Clinical evaluation of a (1,3)-ß-D-glucan assay for presumptive diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients. Clin Vaccine Immunol. 2009;16:1524–1526.
   PubMed Web of Science ®Google Scholar
• Engsbro AL, Najat S, Jørgensen KM, et al. Diagnostic accuracy of the 1,3-ß-D-glucan test for pneumocystis pneumonia in a tertiary university hospital in Denmark: A retrospective study. Med Mycol. 2019;57:710–717.
   Web of Science ®Google Scholar
• Ginocchio F, Verrina E, Furfaro E, et al. Case report of the reliability 1,3-ß-D-glucan monitoring during treatment of peritoneal candidiasis in a child receiving continuous peritoneal dialysis. Clin Vaccine Immunol. 2012;19:626–627.
   PubMed Web of Science ®Google Scholar
• Naselli A, Faraci M, Lanino E, et al. Persistence of high-level (1,3)-ß-D-glucan after candidemia following autologous peripheral SCT in a pediatric patient. Bone Marrow Transplant. 2015;50:137–138.
   PubMed Web of Science ®Google Scholar
• Kedzierska A, Kochan P, Pietrzyk A, et al. Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1?3)-ß-D-glucan antigens. Eur J Clin Microbiol Infect Dis. Springer Verlag. 2007;26(11): 755–766.
   PubMed Web of Science ®Google Scholar
• Smith PB, Benjamin DK, Alexander BD, et al. Quantification of 1,3-ß-D-glucan levels in children: preliminary data for diagnostic use of the ß-glucan assay in a pediatric setting. Clin Vaccine Immunol. 2007;14:924–925.
   PubMed Web of Science ®Google Scholar
• Marty FM, Lowry CM, Lempitski SJ, et al. Reactivity of (1?3)-ß-D-glucan assay with commonly used intravenous antimicrobials. Antimicrob Agents Chemother. 2006;50:3450–3453.
   PubMed Web of Science ®Google Scholar
• Koo S, Bryar JM, Page JH, et al. Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease. Clin Infect Dis. 2009;49:1650–1659.
   PubMed Web of Science ®Google Scholar
• Racil Z, Kocmanova I, Lengerova M, et al. Difficulties in using 1,3-ß-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies - High frequency of false-positive results and their analysis. J Med Microbiol. 2010;59:1016–1022.
   PubMed Web of Science ®Google Scholar
• Goudjil S, Chazal C, Moreau F, et al. Blood product transfusions are associated with an increase in serum (1–3)-beta-d-glucan in infants during the initial hospitalization in neonatal intensive care unit (NICU). J Matern Neonatal Med. 2017;30:933–937.
   PubMed Web of Science ®Google Scholar
• Usami M, Ohata A, Horiuchi T, et al. Positive (1-->3)-beta-D-glucan in blood components and release of (1-->3)-beta-D-glucan from depth-type membrane filters for blood processing. Transfusion. 2002;42:1189–1195.
   PubMed Web of Science ®Google Scholar
• Klont RR, Mennink-Kersten MASH, Verweij PE. Utility of Aspergillus antigen detection in specimens other than serum specimens. Clin Infect Dis. 2004;39:1467–1474.
   PubMed Web of Science ®Google Scholar
• Tortorano AM, Esposto MC, Prigitano A, et al. Cross-reactivity of Fusarium spp. in the Aspergillus galactomannan enzyme-linked immunosorbent assay. J Clin Microbiol. 2012;50:1051–1053.
   PubMed Web of Science ®Google Scholar
• Wheat LJ, Hackett E, Durkin M, et al. Histoplasmosis-associated cross-reactivity in the biorad platelia Aspergillus enzyme immunoassay. Clin Vaccine Immunol. 2007;14:638–640.
   PubMed Web of Science ®Google Scholar
• Viscoli C, Machetti M, Gazzola P, et al. Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis. J Clin Microbiol. 2002;40:1496–1499.
   PubMed Web of Science ®Google Scholar
• Machetti M, Zotti M, Veroni L, et al. Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole. Transpl Infect Dis. 2000;2:140–144.
   PubMedGoogle Scholar
• Roilides E, Pavlidou E, Papadopoulos F, et al. Cerebral aspergillosis in an infant with corticosteroid-resistant nephrotic syndrome. Pediatr Nephrol. 2003;18:450–453.
   PubMed Web of Science ®Google Scholar
• Chen TK, Groncy PK, Javahery R, et al. Successful treatment of Aspergillus ventriculitis through voriconazole adaptive pharmacotherapy, immunomodulation, and therapeutic monitoring of cerebrospinal fluid (1?3)-ß-D-glucan. Med Mycol. Oxford University Press. 2017;55:109–117.
   PubMed Web of Science ®Google Scholar
• Lehrnbecher T, Rath PM, Attarbaschi A, et al. Galactomannan and PCR in the central nervous system to detect invasive mold disease - a retrospective analysis in immunocompromised children. Sci Rep. 2019;9:12950.
   PubMed Web of Science ®Google Scholar
• Sulahian A, Touratier S, Ribaud P. False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med. 2003;349:2366–2367.
   PubMed Web of Science ®Google Scholar
• Mennink-Kersten MASH, Ruegebrink D, Klont RR, et al. Bifidobacterial lipoglycan as a new cause for false-positive platelia Aspergillus enzyme-linked immunosorbent assay reactivity. J Clin Microbiol. 2005;43:3925–3931. Available from http://www.ncbi.nlm.nih.gov/pubmed/16081932
   PubMed Web of Science ®Google Scholar
• Mori Y, Nagasaki Y, Kamezaki K, et al. High incidence of false-positive Aspergillus galactomannan test in multiple myeloma. Am J Hematol. 2010;85:449–451. Available from http://www.ncbi.nlm.nih.gov/pubmed/20513124
   PubMed Web of Science ®Google Scholar
• Müller FM, Werner KE, Kasai M, et al. Rapid extraction of genomic DNA from medically important yeasts and filamentous fungi by high-speed cell disruption. J Clin Microbiol. 1998;36:1625–1629.
   PubMed Web of Science ®Google Scholar
• Harrison E, Stalhberger T, Whelan R, et al. Aspergillus DNA contamination in blood collection tubes. Diagn Microbiol Infect Dis. 2010;67:392–394.
   PubMed Web of Science ®Google Scholar
• Reinwald M, Hummel M, Kovalevskaya E, et al. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies. J Antimicrob Chemother. 2012;67:2260–2267.
   PubMed Web of Science ®Google Scholar
• Kadmon G, Nahum E, Sprecher H, et al. Polymerase-chain-reaction-based diagnosis of invasive fungal pulmonary infections in immunocompromised children. Pediatr Pulmonol. 2012;47:994–1000.
   PubMed Web of Science ®Google Scholar
• Hikida S, Tanaka Y, Tsuru T, et al. The fungal DNA examination is useful as a sensitive parameter for the initiation and the quit of antifungal therapy in immunocompromised pediatric patients after surgery. Kurume Med J. 2004;51:125–131.
   PubMedGoogle Scholar
• Mokaddas E, Burhamah MHA, Khan ZU, et al. Levels of (1?3)-ß-D-glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candida species. BMC Infect Dis. 2010;10(1): 292.
   PubMedGoogle Scholar
• Taira CL, Okay TS, Delgado AF, et al. A multiplex nested PCR for the detection and identification of Candida species in blood samples of critically ill paediatric patients. BMC Infect Dis. 2014;14(1): 406.
   PubMedGoogle Scholar
• Samuel CM, Whitelaw A, Corcoran C, et al. Improved detection of Pneumocystis jirovecii in upper and lower respiratory tract specimens from children with suspected pneumocystis pneumonia using real-time PCR: a prospective study. BMC Infect Dis. 2011;11: 329.
   PubMed Web of Science ®Google Scholar
• Morrow BM, Samuel CM, Zampoli M, et al. Pneumocystis pneumonia in South African children diagnosed by molecular methods. BMC Res Notes. 2014; 7(1): 26.
   PubMedGoogle Scholar
• Shigemura T, Nakazawa Y, Matsuda K, et al. Serial monitoring of Mucorales DNA load in serum samples of a patient with disseminated mucormycosis after allogeneic bone marrow transplantation. Int J Hematol. 2014;100:206–209.
   PubMed Web of Science ®Google Scholar
• Shigemura T, Nakazawa Y, Matsuda K, et al. Evaluation of Mucorales DNA load in cerebrospinal fluid in a patient with possible cerebral mucormycosis treated with intravenous liposomal amphotericin B. Int J Infect Dis. 2014;29:e200–e202.
   PubMed Web of Science ®Google Scholar
• Ramos JT, Villar SBouza E. Performance of a quantitative pcr-based assai and beta-d-glucan detection for diagnosis of invasive candidiasis in very low birth weight preterm neonatal patients (candineo study). J Clin Microbiol. 2017;55:2752–2764.
   PubMed Web of Science ®Google Scholar
• Sendid B, Jouault T, Coudriau R, et al. Increased sensitivity of mannanemia detection tests by joint detection of a- and ß-linked oligomannosides during experimental and human systemic candidiasis. J Clin Microbiol. 2004;42:164–171.
   PubMed Web of Science ®Google Scholar
• Mikulska M, Calandra T, Sanguinetti M, et al. The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit Care. 2010;14:R222.
   PubMed Web of Science ®Google Scholar
• Rao DSVR, Ghosh A, Singhi S, et al. Mannan antigen detection in the diagnosis of patients with invasive candidiasis. Indian J Med Res. 2002;116:13–20.
   PubMed Web of Science ®Google Scholar
• Castagnola E, Bagnasco F, Amoroso L, et al. Role of management strategies in reducing mortality from invasive fungal disease in children with cancer or receiving hemopoietic stem cell transplant: a single center 30-year experience. Pediatr Infect Dis J. 2014;33:233–237.
   PubMed Web of Science ®Google Scholar
• Toma P, Bertaina A, Castagnola E, et al. Fungal infections of the lung in children. Pediatr Radiol. 2016;46:1856–1865.
   PubMed Web of Science ®Google Scholar
• Burgos A, Zaoutis TE, Dvorak CC, et al. Pediatric invasive aspergillosis: A multicenter retrospective analysis of 139 contemporary cases. Pediatrics. 2008;121(5), e1286–e1294.
   PubMed Web of Science ®Google Scholar
• Taccone A, Occhi M, Garaventa A, et al. CT of invasive pulmonary aspergillosis in children with cancer. Pediatr Radiol. 1993;23:177–180.
   PubMed Web of Science ®Google Scholar
• Han SB, Kim SK, Lee JW, et al. Serum galactomannan index for early prediction of mortality in immunocompromised children with invasive pulmonary aspergillosis. BMC Infect Dis. 2015;15(1): 271.
   PubMedGoogle Scholar
• Groll AH, Castagnola E, Cesaro S, et al. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation. Lancet Oncol. Lancet Publishing Group.2014; 15(8), e327–e340.
   PubMed Web of Science ®Google Scholar
• Stanzani M, Battista G, Sassi C, et al. Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies. Clin Infect Dis. 2012;54:610–616.
   PubMed Web of Science ®Google Scholar
• Stanzani M, Sassi C, Lewis RE, et al. High resolution computed tomography angiography improves the radiographic diagnosis of invasive mold disease in patients with hematological malignancies. Clin Infect Dis. 2015;60:1603–1610.
   PubMed Web of Science ®Google Scholar
• Lauten M, Attarbaschi A, Cario G, et al. Invasive mold disease of the central nervous system in children and adolescents with cancer or undergoing hematopoietic stem cell transplantation: analysis of 29 contemporary patients. Pediatr Blood Cancer. 2019;66(8): e27806.
   PubMed Web of Science ®Google Scholar
• Castagnola E, Ruberto E, Guarino A. Gastrointestinal and liver infections in children undergoing antineoplastic chemotherapy in the years 2000. World J Gastroenterol. 2016;22:5853–5866. Baishideng Publishing Group Co., Limited
   PubMed Web of Science ®Google Scholar
• Cohn SM, Pokala HR, Siegel JD, et al. Application of a standardized screening protocol for diagnosis of invasive mold infections in children with hematologic malignancies. Support Care Cancer. 2016;24:5025–5033.
   PubMed Web of Science ®Google Scholar
• Ankrah AO, Span LFR, Klein HC, et al. Role of FDG PET/CT in monitoring treatment response in patients with invasive fungal infections. Eur J Nucl Med Mol Imaging. 2019;46:174–183.
   PubMed Web of Science ®Google Scholar
• Leroy-Freschini B, Treglia G, Argemi X, et al. 18F-FDG PET/CT for invasive fungal infection in immunocompromised patients. QJM. [Internet]. 2018; 111:613–622. [cited 2019 Sep 16]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29917146
   PubMed Web of Science ®Google Scholar
• Douglas AP, Thursky KA, Worth LJ, et al. FDG PET/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging. Eur J Nucl Med Mol Imaging. 2019;46:166–173.
   PubMed Web of Science ®Google Scholar
• Hot A, Maunoury C, Poiree S, et al. Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections. Clin Microbiol Infect. 2011;17:409–417.
   PubMed Web of Science ®Google Scholar
• Chawla SC, Federman N, Zhang D, et al. Estimated cumulative radiation dose from PET/CT in children with malignancies: A 5-year retrospective review. Pediatr Radiol. 2010;40:681–686.
   PubMed Web of Science ®Google Scholar
• León C, Ruiz-Santana S, Saavedra P, et al. A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med. 2006;34:730–737.
   PubMed Web of Science ®Google Scholar
• Benjamin DK, Stoll BJ, Gantz MG, et al. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics. 2010;126:e865–73.
   PubMed Web of Science ®Google Scholar
• Castagnola E, Buratti S. Clinical aspects of invasive candidiasis in paediatric patients. Drugs. 2009;69 (Suppl_1):45–50.
   PubMed Web of Science ®Google Scholar
• Benjamin DK Jr, DeLong ER, Steinbach WJ, et al. Empirical therapy for neonatal candidemia in very low birth weight infacts. Pediatrics. 2003;112:543–547.
   PubMed Web of Science ®Google Scholar
• Benjamin DR Jr, Stoll BJ, Fanaroff AA, et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics. 2006;117:84–92.
   PubMed Web of Science ®Google Scholar
• Manzoni P, Farina D, Galletto P, et al. Type and number of sites colonized by fungi and risk of progression to invasive fungal infection in preterm neonates in neonatal intensive care unit. J Perinat Med. 2007;35:220–226.
   PubMed Web of Science ®Google Scholar
• Lee JH, Homik CP, Benjamin DK, et al. Risk factors for invasive candidiasis in infants >1500 g birth weight. Pediatr Infect Dis J. 2013;32:222–226.
   PubMed Web of Science ®Google Scholar
• Zaoutis TE, Prasad PA, Localio AR, et al. Risk factors and predictors for Candidemia in pediatric intensive care unit patients: implications for prevention. Clin Infect Dis. 2010;51:e38–e45.
   PubMed Web of Science ®Google Scholar
• Manzoni P, Castagnola E, Mostert M, et al. Hyperglycaemia as a possible marker of invasive fungal infection in preterm neonates. Acta Pediatr. 2006;95:486–493.
   PubMed Web of Science ®Google Scholar
• Fisher BT, Ross RK, Roilides E, et al. Failure to validate a multivariable clinical prediction model to identify pediatric intensive care unit patients at high risk for Candidemia. J Pediatr Infect Dis Soc. 2015;5:456–461.
   Web of Science ®Google Scholar
• Fraser M, Brown Z, Houldsworth M, et al. Rapid identification of 6328 isolates of pathogenic yeasts using MALDI-ToF MS and a simplified, rapid extraction procedure that is compatible with the bruker biotyper platform and database. Med Mycol. 2016;54:80–88.
   PubMed Web of Science ®Google Scholar
• Mellmann A, Bimet F, Bizet C, et al. High interlaboratory reproducibility of matrix-assisted laser desorption ionization-time of flight mass spectrometry-based species identification of nonfermenting bacteria. J Clin Microbiol. 2009;47:3732–3734.
   PubMed Web of Science ®Google Scholar
• Kostrzewa M PA. Advances in MALDI and laser- induced soft ionization mass spectrometry. In: Springer, editor. Cramer R. 2016. p. 227–246.
   Google Scholar
• Rojas FD, Sosa MDLA, Fernández MS, et al. Antifungal susceptibility of Malassezia furfur, Malassezia sympodialis, and Malassezia globosa to azole drugs and amphotericin B evaluated using a broth microdilution method. Med Mycol. 2014;52:641–646.
   PubMed Web of Science ®Google Scholar
• Sewell DL, Pfaller MA, Barry AL. Comparison of broth macrodilution, broth microdilution, and E test antifungal susceptibility tests for fluconazole. J Clin Microbiol. 1994;32:2099–2102.
   PubMed Web of Science ®Google Scholar
• Leli C, Ferranti M, Moretti A, et al. Procalcitonin levels in gram-positive, gram-negative, and fungal bloodstream infections. Dis Markers. 2015;2015:701480.
   PubMed Web of Science ®Google Scholar
• Dou Y-H, Du J-K, Liu H-L, et al. The role of procalcitonin in the identification of invasive fungal infection-a systemic review and meta-analysis. Diagn Microbiol Infect Dis. 2013;76:464–469.
   PubMed Web of Science ®Google Scholar
• Wu Q, Yang H, Kang Y. Combined assessment of ?PCT and ?CRP could increase the ability to differentiate candidemia from bacteremia. Crit Care. 2019;23:271.
   PubMed Web of Science ®Google Scholar
• Dornbusch HJ, Strenger V, Kerbl R, et al. Procalcitonin - A marker of invasive fungal infection? Support Care Cancer. 2005;13:343–346.
   PubMed Web of Science ®Google Scholar
• Giacobbe DR, Mikulska M, Tumbarello M, et al. Combined use of serum (1,3)-ß-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units. Crit Care. 2017;21:176.
   PubMed Web of Science ®Google Scholar
• Shen HP, Tang YM, Song H, et al. Efficiency of interleukin 6 and interferon gamma in the differentiation of invasive pulmonary aspergillosis and pneumocystis pneumonia in pediatric oncology patients. Int J Infect Dis. 2016;48:73–77.
   PubMed Web of Science ®Google Scholar
• Neely LA, Audeh M, Phung NA, et al. T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood. Sci Transl Med. 2013;5(182): 182ra54–182ra54.
   PubMed Web of Science ®Google Scholar
• Hamula CL, Hughes K, Fisher BT, et al. T2Candida provides rapid and accurate species identification in pediatric cases of Candidemia. Am J Clin Pathol. 2016;145:858–861.
   PubMed Web of Science ®Google Scholar
• Fanos V, Van Den Anker J, Noto A, et al. Metabolomics in neonatology: fact or fiction? Semin. Fet Neonat Med. 2013;18:3–12.
   PubMed Web of Science ®Google Scholar
• Dessì A, Corsello G, Stronati M, et al. New diagnostic possibilities in systemic neonatal infections: metabolomics. Early Hum Dev. 2014;90(Suppl 1):S19–21.
   PubMedGoogle Scholar
• Nicholson JK, Connelly J, Lindon JC, et al. Metabonomics: A platform for studying drug toxicity and gene function. Nat Rev Drug Discov. 2002;1(2): 153.
   PubMed Web of Science ®Google Scholar
• Dessì A, Liori B, Caboni P, et al. Monitoring neonatal fungal infection with metabolomics. J Matern Fetal Neonatal Med. 2014;27(Suppl 2):34–38.
   PubMedGoogle Scholar
• Rolle A-M, Hasenberg M, Thornton CR, et al. ImmunoPET/MR imaging allows specific detection of Aspergillus fumigatus lung infection in vivo. Proc Natl Acad Sci U S A. 2016;113:E1026–33.
   PubMed Web of Science ®Google Scholar
• Warris A, Pana Z-D, Oletto A, et al., Etiology and outcome of candidemia in neonates and children in Europe: an 11-year multinational retrospective study. Pediatr Infect Dis J. In press.
   Google Scholar